Annual report pursuant to Section 13 and 15(d)

Long-Term Debt (Details)

v3.3.1.900
Long-Term Debt (Details)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Oct. 31, 2014
USD ($)
installment
Dec. 31, 2015
USD ($)
Jun. 30, 2015
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Dec. 22, 2015
USD ($)
Debt Instrument [Line Items]            
Payments for Fees       $ 1,600    
Gains (Losses) on Extinguishment of Debt       1,873 $ 0  
Subordinated note payable     $ 10,700      
Interest Expense       3,705 602  
Debt Instrument, Unamortized Discount   $ 2,300   2,300    
Exit Fee       1,400    
Deferred Finance Costs, Net         300  
Amortization of Financing Costs   200        
Amortization of Deferred Loan Origination Fees, Net   300        
Notes Payable, Other Payables            
Debt Instrument [Line Items]            
Subordinated note payable $ 11,000          
Long-term debt   8,400   8,400    
RedPath Integrated Pathology, Inc | Notes Payable, Other Payables            
Debt Instrument [Line Items]            
Face amount $ 11,000          
Stated interest rate 5.00%          
Subordinated note payable $ 7,517          
Interest Expense       800 $ 100  
Long-term debt   7,300   7,300    
Number of equal consecutive quarterly installments | installment 8          
RedPath Integrated Pathology, Inc | Loans            
Debt Instrument [Line Items]            
Face amount $ 20,000         $ 20,000
Proceeds from issuance of debt 19,600          
Debt issuance cost 100          
Interest Expense       100    
Long-term debt   $ 18,800   $ 18,800    
Loan Processing Fee 300          
Exit Fee $ 800